Samsung Bioepis Co., Ltd. announced today that the Phase 1 and Phase 3 studies on SB27, a proposed biosimilar to Keytruda 1 (pembrolizumab), have met their primary endpoints.
Afghan officials say overnight airstrikes by Pakistani forces have killed at least 36 civilians and injured more than 160 ...
A record-breaking heat wave has overwhelmed mortuaries in Paris, leaving funeral directors struggling to find space for bodies ...
An attorney in Washington state promised “miracles” to tens of thousands of immigrants seeking legal status in the United States. Instead, Alexandra Lozano created fake stories of domestic abuse and ...
KAYTUS, ein führender Anbieter von KI-Infrastruktur und Flüssigkeitskühlungslösungen, hat auf der ISC 2026 zwei zentrale Lösungen für KI-Rechenzentren der nächsten Generation vorgestellt: eine vollstä ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results